You have 9 free searches left this month | for more free features.

ABSSSI

Showing 1 - 25 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Skin Infection Trial in Saint Louis (Dalbavancin)

Terminated
  • Skin Infection
  • Saint Louis, Missouri
    Barnes-Jewish Hospital
Oct 14, 2021

Diabetes, Wound Infection, ABSSSI Trial in Hartford (Tebipenem Pivoxil Hydrobromide)

Enrolling by invitation
  • Diabetes
  • +3 more
  • Tebipenem Pivoxil Hydrobromide
  • Hartford, Connecticut
    Hartford Hospital
Mar 4, 2022

Dalbavancin and Other Standard of Care of Same Class in ABSSSI

Completed
  • Acute Bacterial Skin and Skin Structure Infection
  • Xydalba
  • vancomycin, teicoplanin or daptomycin
  • Alexandroupolis, Greece
  • +15 more
Mar 3, 2022

Acute Bacterial Skin and Skin Structure Infection Trial in United States (Current Formulation of Oritavancin, Kimyrsa)

Completed
  • Acute Bacterial Skin and Skin Structure Infection
  • Current Formulation of Oritavancin
  • Kimyrsa
  • Chula Vista, California
  • +3 more
Mar 18, 2021

Bacterial Infections, Infection Trial in United States (BC-3781, Vancomycin)

Completed
  • Bacterial Infections
  • Infection
  • Chula Vista, California
  • +8 more
Oct 29, 2020

Sivextro in Acute Bacterial Skin and Skin Structure Infection in

Terminated
  • Skin Disease, Infectious
  • Multiple Locations, Mexico
  • +2 more
Sep 30, 2019

Acute Bacterial Skin and Skin Structure Infections Trial in India (Oral Levonadifloxacin/Linezolid Tablet, Intravenous

Completed
  • Acute Bacterial Skin and Skin Structure Infections
  • Oral Levonadifloxacin/Linezolid Tablet
  • Intravenous Levonadifloxacin/Linezolid Infusion
  • Hyderabad, Andhra Pradesh, India
  • +31 more
Jun 26, 2020

Bacterial Infections, Acute Bacterial Skin and Skin Structure Infection Trial in New York (Dalbavancin, Usual Care)

Completed
  • Bacterial Infections
  • Acute Bacterial Skin and Skin Structure Infection
  • New York, New York
    Weill Cornell Medicine
Jan 7, 2020

Acute Bacterial Skin and Skin Structure Infections Trial in United States (Usual Care, Dalbavancin)

Completed
  • Acute Bacterial Skin and Skin Structure Infections
  • Phoenix, Arizona
  • +10 more
Mar 27, 2020

Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide

Recruiting
  • Methicillin-Resistant Staphylococcus Aureus
  • +2 more
  • Dalbavancin single dose
  • +2 more
  • Mobile, Alabama
  • +26 more
Jan 27, 2023

Acute Bacterial Skin and Skin Structure Infections Trial in Worldwide (ceftobiprole medocaril, vancomycin+aztreonam)

Completed
  • Acute Bacterial Skin and Skin Structure Infections
  • Anaheim, California
  • +33 more
Mar 7, 2022

Skin and Subcutaneous Tissue Bacterial Infections, Gram-Positive Bacterial Infections Trial in San Diego (TNP-2092, Vancomycin)

Completed
  • Skin and Subcutaneous Tissue Bacterial Infections
  • Gram-Positive Bacterial Infections
  • San Diego, California
    eStudy Site
Oct 10, 2020

Dalbavancin Real-life Utilization in Diabetic Patients Suffering

Recruiting
  • Diabetes
  • Infection
  • Asti, Italy
  • +10 more
Mar 9, 2022

Bacterial Infections Trial in United States (Debio 1450 IV, Debio 1450 Oral, Linezolid)

Completed
  • Bacterial Infections
  • Debio 1450 IV
  • +5 more
  • Anaheim, California
  • +21 more
Oct 24, 2019

Bacterial Infections Trial in France (Xydalba)

Completed
  • Bacterial Infections
  • Ajaccio, France
  • +14 more
Jul 19, 2021

Wound Infection, Abscess, Systemic Inflammation Trial in La Mesa (Single-Dose IV Oritavancin Diphosphate, IV Vancomycin)

Completed
  • Wound Infection
  • +3 more
  • Single-Dose IV Oritavancin Diphosphate
  • IV Vancomycin
  • La Mesa, California
    Sharp Grossmont Hospital
Apr 12, 2021

Skin Infection Trial in Shanghai (9MW1411 injection 1 combined with Linezolid, 9MW1411 injection 2 combined with Linezolid,

Recruiting
  • Skin Infection
  • 9MW1411 injection 1 combined with Linezolid
  • +2 more
  • Shanghai, Shanghai, China
    Huashan Hospital affiliated to Fudan University
Apr 15, 2022

Bacterial Infections, Skin Structures and Soft Tissue Infections Trial in Worldwide (Omadacycline, Linezolid)

Completed
  • Bacterial Infections
  • Skin Structures and Soft Tissue Infections
  • Mobile, Alabama
  • +77 more
Mar 20, 2019

Skin Diseases, Bacterial, Gram-Positive Bacterial Infections Trial in United States (contezolid acefosamil, linezolid 600 mg)

Completed
  • Skin Diseases, Bacterial
  • Gram-Positive Bacterial Infections
  • contezolid acefosamil
  • linezolid 600 mg
  • Chula Vista, California
  • +6 more
Apr 6, 2021

Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Non-healing Wound Trial (Ultrasonic Drug Delivery, Standard of Care

Unknown status
  • Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
  • Non-healing Wound
  • Ultrasonic Drug Delivery
  • Standard of Care Antibiotic Treatment
  • (no location specified)
Nov 4, 2018

Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders Trial in Aurora (Dalbavancin)

Enrolling by invitation
  • Gram-Positive Bacterial Infections
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
May 4, 2021

Skin and Subcutaneous Tissue Bacterial Infections Trial in United States (Delafloxacin, Linezolid, Vancomycin)

Completed
  • Skin and Subcutaneous Tissue Bacterial Infections
  • Mobile, Alabama
  • +30 more
Sep 25, 2019

Skin Infection, Bacterial Infection Trial in United States (Daptomycin, Brilacidin)

Completed
  • Skin Infection
  • Bacterial Infection
  • Chula Vista, California
  • +3 more
Sep 24, 2018

Xydalba Utilization Registry in Germany

Terminated
  • Bacterial Infections
  • Essen, Germany
  • +6 more
Jul 15, 2020

Bacterial Infections, Skin Structures and Soft Tissue Infections Trial in United States (Omadacycline, Linezolid)

Completed
  • Bacterial Infections
  • Skin Structures and Soft Tissue Infections
  • Birmingham, Alabama
  • +49 more
Nov 28, 2018